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Background
The current lack of predictable central nervous system
(CNS) models in pharmaceutical industry early stage
development strongly contributes for the high attrition
rates registered for new therapeutics [1]. Thus, there is an
increasing need for a paradigm shift towards more human
relevant cell models, which can closely recapitulate the in
vivo cell-cell interactions, presenting higher physiological
relevance by bridging the gap between animal models and
human clinical trials. In this context, human 3D in vitro
models are promising tools with great potential for pre-
clinical research, as they can mimic some of the main fea-
tures of tissues, such as cell-cell and cell-extracellular
matrix (ECM) interactions [2,3]. Moreover these complex
cell models are suitable for high-throughput screening
(HTS) platforms, essential in drug discovery pipelines by
reducing both costs and time in clinical trials [2,4]. How-
ever, despite important advances in the last years and the
increasing clinical and biological relevance, the full estab-
lishment of human 3D in vitro models in pre-clinical
research requires a significant increase in the power of the
available analytical methodologies towards more robust
and comprehensive readouts [4]. With the emergence of
systems biology field and several “-omics” technologies,
such as metabolomics, it became possible to have a more
mechanistic approach in the understanding of cellular pro-
grams. 1H-nuclear magnetic resonance (1H-NMR) spec-
troscopy is a powerful and widely accepted high resolution
methodology for a number of applications, including
metabolic profiling [5]. Despite the low sensitivity when
compared with mass spectrometry (MS), 1H-NMR profil-
ing presents several advantages, enabling a non-invasive
and non-destructive quantitative analysis requiring only
minimal sample preparation [5].
In this work we present the development of a robust
and optimized workflow for the exometabolome profiling




hmNPC were isolated and routinely propagated in static
conditions, on poly-L-ornithine-fibronectin (PLOF) coated
plates, in serum-free expansion medium, containing basic
fibroblast growth factor and epidermal growth factor, as
previously reported [6]. hmNSC were cultured in stirred
systems as neurospheres for 7 days, with a 50% media
changes every at day 3 [7]. All experiments were per-
formed in 500 mL shake flasks (80 mL working volume),
with orbital shaking at 100 rpm. Cultures were maintained
at 37°C, in 3% O2 and 5% CO2.
Sample Preparation
Neurospheres harvested at day 7 were plated on PLOF-
coated plates. A washing step with PBS was performed
before adding fresh medium (Neurobasal medium (Invitro-
gen) supplemented with 2% of B27, 2 mM of Glutamax
(Invitrogen), 100 μM dibutyryl c-AMP (Sigma-Aldrich),
and 10 μg/mL gentamycin (Invitrogen)) to the culture.
Samples of supernatant were then collected at 6, 12, 24
and 48 hours after media exchange and stored at -20°C.
Neurospheres were harvested and total protein was quanti-
fied with Micro BCA Protein Assay Kit (Pierce), according
to manufacturer’s instructions. Prior to NMR analysis,
samples were thawed and filtered using Vivaspin 500 col-
umns (Sigma-Aldrich) at 14,000xg, in order to remove high
molecular weight proteins and lipids that induce baseline
distortions and peak broadening due to protein binding.
To minimize variations in pH, 400 μL of filtered samples
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were mixed with 200 μL of phosphate buffer (50 mM, pH
7.4) with 5 mM DSS-d6 [8].
1H-NMR spectra acquisition and profiling
For NMR analysis, 500 μL of the resulting supernatants
were placed into 5 mm NMR tubes. All 1H-NMR spectra
were recorded at 25°C on a Bruker Avance II+ 500 MHz
NMR spectrometer. One-dimensional (1D) spectra were
recorded using a NOESY-based pulse sequence (4 s acqui-
sition time, 1 s relaxation time and 100 ms mixing time).
Typically, 256 scans were collected for each spectrum. All
spectra were phase and baseline corrected automatically,
with fine adjustments performed manually. Spectra analysis
was performed using Chenomx NMR Suite 7.1, using DSS-
d6 as internal standard for quantification of metabolites.
Results
The approach applied in this study for metabolic profiling
of the hmNPC cultures using 1H-NMR enables an accu-
rate screening of a wide range of metabolites in the extra-
cellular environment (Figure 1A), including amino acids,
glucose, lactate, among other substrates and by-products.
Metabolism plasticity has been widely described as clo-
sely related with cell pluri/multipotency and cell fate.
Figure 1 Typical 1H-NMR spectra for hmNPC culture at different time points (A). Concentration profiles of the main metabolites quantified
in the exometabolome of hmNPC cultures that have significantly changed during 48h of culture (B).
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Stemness programs and cell identity determination are
driven mainly by genetic and epigenetic switches, which
can modulate cell metabolism, among other cell fate path-
ways [9]. Thus, the transition from pluri/multipotency
towards somatic cell lineages is accompanied by significant
metabolic shifts, mainly at energy metabolism levels. In
this context, the metabolic study of in vitro cultures of
stem cells may contribute with valuable knowledge for the
mechanistic understanding of stemness and differentiation
pathways.
Our results showed that the hmNPC in an undifferen-
tiated state presented a highly glycolytic metabolism, with
high glucose consumption and lactate production rates
(Figure 1B), in agreement with previous reports for murine
NPC [10]. The profiles observed for glucose consumption
and lactate synthesis suggest an almost complete conver-
sion of pyruvate, generated as the final product of glycoly-
sis, to lactate. One key culture parameter that can greatly
contribute for a low oxidative metabolism is the fact that
neural stem/progenitor cells are typically cultured under
physiological low oxygen tension environments. Hypoxic
conditions have been widely described as critical for main-
taining cell viability and self-renewal, while promoting
proliferation and influencing cell fate during differentia-
tion [11]. Moreover, the consumption and depletion of
pyruvate present in culture media may suggest not only its
conversion to lactate, but may also contribute for the
observed alanine synthesis.
Interestingly, even though glutamate could not be
detected at significant levels, an accumulation of pyro-
glutamate was observed, which can be found as N-term-
inal modification in many neuronal peptides, including
pathological accumulating peptides as b-amyloid in
Alzheimer’s disease. As a free metabolite pyroglutamate
can derive both from degradation of proteins containing
N-terminal residues or from glutamate/glutamine cycliza-
tion. Although it is still a matter of debate, pyroglutamate
may act as a reservoir of neural glutamate, which is the
main excitatory neurotransmitter in CNS and in high
levels becomes a major neurotoxicant [12].
Concerning branched-chain amino acids (BCAA) meta-
bolism it was possible to observe the extracellular accumu-
lation of 2-oxoisocaproate and methylsuccinate as main
by-products, although in low rates. In brain metabolism
the balance between leucine and 2-oxisocaproate has par-
ticular relevance through the establishment of a nitrogen
turnover cycle where astroglia cells catabolize leucine into
2-oxoisocaproate, which is then taken up by neurons and
converted back into leucine [13,14].
Conclusions
The methodology presented in this work, enables a
straightforward approach for an accurate and reproducible
metabolic profiling of multipotent hmNPC 3D cultures.
This methodology provides a robust alternative to an array
of laborious analytical methods, by taking advantage of the
fast and simple sample preparation for NMR spectroscopy
and the ease of user-friendly software for spectra profiling,
which is often a challenging and time-consuming process
due to peak overlapping in complex mixtures such as the
mammalian cell culture media. Moreover, this approach
can be applied to other multi/pluripotent cell sources, not
only for metabolic profiling of in vitro cultures but also to
study the impact of new therapeutics or toxicants, contri-
buting to generate invaluable data in drug development
cascades.
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